Summary

Persistence Market Research has recently released a comprehensive report on the global Tuberculosis Diagnostics Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report delivers a detailed overview of the market landscape to support strategic and data-driven decision-making by stakeholders.

Key Insights:

• Tuberculosis Diagnostics Market Size (2025E): US$ 33.8 Bn
• Projected Market Value (2032F): US$ 50.1 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 5.8%

Tuberculosis Diagnostics Market – Report Scope:

The tuberculosis diagnostics market comprises a broad range of diagnostic tests and technologies used to detect Mycobacterium tuberculosis infections. These diagnostics include molecular tests, smear microscopy, and radiography-based methods deployed across hospitals, clinics, and diagnostic centers. The market plays a critical role in global public health by enabling early detection, treatment monitoring, and disease control. Rising tuberculosis prevalence, increased government initiatives for TB eradication, and advancements in molecular diagnostics are key contributors to market expansion. Growing awareness of early diagnosis and improvements in healthcare infrastructure, particularly in high-burden regions, are further supporting market growth during the forecast period.

Market Growth Drivers:

The growth of the global tuberculosis diagnostics market is primarily driven by the increasing global burden of tuberculosis, particularly in developing and underdeveloped regions. Government-led TB control programs, supported by international organizations, have significantly increased funding for diagnostic screening and early detection initiatives. Technological advancements in nucleic acid testing, which offer faster and more accurate results compared to conventional methods, are further accelerating adoption. Additionally, rising awareness about multidrug-resistant tuberculosis (MDR-TB) and the need for rapid diagnostic solutions in clinical settings are contributing to sustained market growth.

Market Restraints:

Despite steady growth prospects, the tuberculosis diagnostics market faces certain challenges. High costs associated with advanced molecular diagnostic technologies can limit adoption in low-income and resource-constrained regions. Limited access to modern diagnostic infrastructure in rural and remote areas also restricts market penetration. Moreover, shortages of skilled laboratory professionals and variability in diagnostic accuracy of traditional methods, such as smear microscopy, pose challenges to effective disease detection and market expansion.

Market Opportunities:

The market presents significant opportunities driven by increasing investments in healthcare infrastructure and diagnostic capabilities across emerging economies. The growing focus on point-of-care and rapid diagnostic tests offers opportunities for innovation and product development. Expansion of public–private partnerships aimed at TB elimination, along with rising demand for diagnostics capable of detecting drug-resistant strains, is expected to create new growth avenues. Furthermore, untapped markets in regions with high TB prevalence, such as South Asia, Africa, and parts of East Asia, provide substantial long-term growth potential for market participants.

Competitive Analysis:

• Abbott
• QIAGEN
• Thermo Fisher Scientific Inc.
• BD
• F. Hoffmann-La Roche AG
• Hologic, Inc.
• Cepheid
• DiaSorin S.p.A.
• Hain Lifescience GmbH
• Oxford Immunotec
• Others

Market Segmentation

By Test Type:

• Nucleic Acid Testing
• Smear Microscopy
• Radiography Tests

By End User:

• Hospitals & Clinics
• Diagnostic Centres
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia & Oceania
• East Asia
• The Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Tuberculosis Diagnostics Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Value Chain Analysis
3.3. Regulatory Scenario
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
4. Global Tuberculosis Diagnostics Market Outlook
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global Tuberculosis Diagnostics Market Outlook: Test Type
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Test Type, 2019-2024
4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
4.3.3.1. Nucleic Acid Testing
4.3.3.2. SMEAR Microscopy
4.3.3.3. Radiography Tests
4.3.4. Market Attractiveness Analysis: Test Type
4.4. Global Tuberculosis Diagnostics Market Outlook: End User
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
4.4.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
4.4.3.1. Hospitals & Clinics
4.4.3.2. Diagnostics Centres
4.4.3.3. Others
4.4.4. Market Attractiveness Analysis: End User
5. Global Tuberculosis Diagnostics Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Tuberculosis Diagnostics Market Outlook
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
6.2.1. By Country
6.2.2. By Test Type
6.2.3. By End User
6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
6.3.1. U.S.
6.3.2. Canada
6.4. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
6.4.1. Nucleic Acid Testing
6.4.2. SMEAR Microscopy
6.4.3. Radiography Tests
6.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
6.5.1. Hospitals & Clinics
6.5.2. Diagnostics Centres
6.5.3. Others
6.6. Market Attractiveness Analysis
7. Europe Tuberculosis Diagnostics Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Test Type
7.2.3. By End User
7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Rest of Europe
7.4. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
7.4.1. Nucleic Acid Testing
7.4.2. SMEAR Microscopy
7.4.3. Radiography Tests
7.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
7.5.1. Hospitals & Clinics
7.5.2. Diagnostics Centres
7.5.3. Others
7.6. Market Attractiveness Analysis
8. East Asia Tuberculosis Diagnostics Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Test Type
8.2.3. By End User
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
8.4.1. Nucleic Acid Testing
8.4.2. SMEAR Microscopy
8.4.3. Radiography Tests
8.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
8.5.1. Hospitals & Clinics
8.5.2. Diagnostics Centres
8.5.3. Others
8.6. Market Attractiveness Analysis
9. South Asia & Oceania Tuberculosis Diagnostics Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Test Type
9.2.3. By End User
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
9.4.1. Nucleic Acid Testing
9.4.2. SMEAR Microscopy
9.4.3. Radiography Tests
9.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
9.5.1. Hospitals & Clinics
9.5.2. Diagnostics Centres
9.5.3. Others
9.6. Market Attractiveness Analysis
10. Latin America Tuberculosis Diagnostics Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Test Type
10.2.3. By End User
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
10.4.1. Nucleic Acid Testing
10.4.2. SMEAR Microscopy
10.4.3. Radiography Tests
10.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
10.5.1. Hospitals & Clinics
10.5.2. Diagnostics Centres
10.5.3. Others
10.6. Market Attractiveness Analysis
11. Middle East & Africa Tuberculosis Diagnostics Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Test Type
11.2.3. By End User
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025-2032
11.4.1. Nucleic Acid Testing
11.4.2. SMEAR Microscopy
11.4.3. Radiography Tests
11.5. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
11.5.1. Hospitals & Clinics
11.5.2. Diagnostics Centres
11.5.3. Others
11.6. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2024
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Abbott
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. QIAGEN
12.3.3. Thermo Fisher Scientific Inc.
12.3.4. BD
12.3.5. F. Hoffmann-La Roche AG
12.3.6. Hologic, Inc.
12.3.7. Cepheid
12.3.8. DiaSorin S.p.A.
12.3.9. Hain Lifescience GmbH
12.3.10. Oxford Immunotec
12.3.11. Others
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations